Terms: = Head and neck cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG AND Diagnosis
28 results:
1. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
2. Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods.
Forooghi Pordanjani T; Dabirmanesh B; Choopanian P; Mirzaie M; Mohebbi S; Khajeh K
Iran Biomed J; 2023 Sep; 27(5):294-306. PubMed ID: 37873683
[TBL] [Abstract] [Full Text] [Related]
3. Contribution of gene polymorphisms on 3p25 to salivary gland carcinoma, ameloblastoma, and odontogenic keratocyst in the Chinese Han population.
Zheng X; Jing J; Yuan M; Liu N; Song Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Aug; 136(2):220-230. PubMed ID: 37495273
[TBL] [Abstract] [Full Text] [Related]
4. Testing of mutations on thyroid nodules with indeterminate cytology: A prospective study of 112 patients in Argentina.
Tolaba N; Spedalletti Y; Bazzoni P; Galindez M; Cerioni V; Santillan C; Richter G; Herrera C; Sanchez L; Van Cawulaert L; Toscano MA; Nallar M; Monteros Alvi M; Moya CM
Endocrinol Diabetes Nutr (Engl Ed); 2022 Feb; 69(2):122-130. PubMed ID: 35256055
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
[No Abstract] [Full Text] [Related]
6. Evaluation of BRAF, RAS, RET/PTC, and PAX8/pparg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.
Bellevicine C; Migliatico I; Sgariglia R; Nacchio M; Vigliar E; Pisapia P; Iaccarino A; Bruzzese D; Fonderico F; Salvatore D; Biondi B; Masone S; Novizio V; Scavuzzo F; Serino D; De Palma M; Chiofalo MG; Botti G; Pezzullo L; Nuzzo V; Spiezia S; De Chiara G; Iorio S; Conzo G; Docimo G; Faggiano A; Bongiovanni M; Malapelle U; Colao A; Triassi M; Troncone G;
Cancer Cytopathol; 2020 Feb; 128(2):107-118. PubMed ID: 31821746
[TBL] [Abstract] [Full Text] [Related]
7. Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the diagnosis of Thyroid Carcinoma.
Bongiovanni M; Sykiotis GP; La Rosa S; Bisig B; Trimech M; Missiaglia E; Gremaud M; Salvatori Chappuis V; De Vito C; Sciarra A; Foulkes WD; Pusztaszeri M
Thyroid; 2020 Jan; 30(1):72-80. PubMed ID: 31701808
[No Abstract] [Full Text] [Related]
8. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/pparg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract] [Full Text] [Related]
9. A user's guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Hung YP; Barletta JA
Histopathology; 2018 Jan; 72(1):53-69. PubMed ID: 29239036
[TBL] [Abstract] [Full Text] [Related]
10. Molecular pathology and thyroid FNA.
Poller DN; Glaysher S
Cytopathology; 2017 Dec; 28(6):475-481. PubMed ID: 29165888
[TBL] [Abstract] [Full Text] [Related]
11. CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.
Wong EHC; Tetter N; Tzankov A; Muller L
Head Neck; 2018 Jan; 40(1):E1-E4. PubMed ID: 29120527
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
[TBL] [Abstract] [Full Text] [Related]
14. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract] [Full Text] [Related]
15. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
Yu J; Mai W; Cui Y; Kong L
J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid cancers.
Yoo SK; Lee S; Kim SJ; Jee HG; Kim BA; Cho H; Song YS; Cho SW; Won JK; Shin JY; Park do J; Kim JI; Lee KE; Park YJ; Seo JS
PLoS Genet; 2016 Aug; 12(8):e1006239. PubMed ID: 27494611
[TBL] [Abstract] [Full Text] [Related]
17. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
Feilchenfeldt J; Varga Z; Siano M; Grabsch HI; Held U; Schuknecht B; Trip A; Hamaguchi T; Gut P; Balague O; Khanfir K; Diebold J; Jochum W; Shoji H; Kushima R; Wagner D; Shimada Y; Cats A; Knuth A; Moch H; Aebi S; Hofer S
Br J Cancer; 2015 Sep; 113(5):716-21. PubMed ID: 26313663
[TBL] [Abstract] [Full Text] [Related]
18. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract] [Full Text] [Related]
19. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
[TBL] [Abstract] [Full Text] [Related]
20. Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.
Giordano TJ; Beaudenon-Huibregtse S; Shinde R; Langfield L; Vinco M; Laosinchai-Wolf W; Labourier E
Hum Pathol; 2014 Jul; 45(7):1339-47. PubMed ID: 24830619
[TBL] [Abstract] [Full Text] [Related]
[Next]
